Effectiveness of a sirolimus-eluting stent (Cypher ®) for diffuse in-stent restenosis inside a bare metal stent

International Heart Journal

Volumn 47, Issue 5, 2006, Pages 651-661

  Sakamoto, Hiroshi ^a,b   Ishikawa, Tetsuya ^a   Mutoh, Makoto ^a   Okada, Hisayuki ^a   Tsurusaki, Tetsushi ^a   Ohta, Masato ^a   Higashitani, Michiaki ^a   Nakano, Yousuke ^a   Fuda, Yuji ^a   Imai, Kamon ^a   Horie, Toshinobu ^a   Mochizuki, Seibu ^b  

^a Saitama Prefectural Cardiovascular and Respiratory Centre   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

In stent restenosis; Sirolimus eluting stent; Stent thrombosis; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; METAL; RAPAMYCIN; TICLOPIDINE;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEATH; DRUG APPROVAL; DRUG EFFICACY; DRUG ELUTING STENT; FEASIBILITY STUDY; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; PATIENT IDENTIFICATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESCRIPTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; REVASCULARIZATION; STATISTICAL SIGNIFICANCE; THROMBOSIS; UNSPECIFIED SIDE EFFECT; VASCULAR PATENCY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; METALS; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; SIROLIMUS; STENTS; TICLOPIDINE;

EID: 33751102615     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.47.651     Document Type: Article

References (33)

1. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331:496-501.
2. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872-8.
3. Eltchaninoff H, Koning R, Tron C, Gupta V, Cribier A. Balloon angioplasty for the treatment of coronary instent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 1998; 32: 980-4.
4. Airoldi F, Rogacka R, Briguori C, et al. Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation vows cutting balloon angioplasty for coronary in-stent restenosis. Am J Cardiol 2004; 94: 1297-300.
5. Spanos V, Stankovic G, Tobis J, Colombo A. The challenge of in-stent restenosis: insights from intravascular ultrasound. Eur Heart J 2003; 24:138-50. (Review)
6. Neumann FJ, Desmet W, Grube E, et al. Effectiveness and Safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005; 111: 2107-11.
7. Colombo A, Orlic D, Stankovic G, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107: 2178-80.
8. Airoldi F, Briguori C, Iakovou I, et al. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis. Am J Cardiol 2006; 97: 1182-7.
9. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated. stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-5.
10. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996; 98: 2277-83.
11. Gregory CR, Huie P, Billingliam ME, Morris RE. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation 1993; 55: 1409-18.
12. Cutlip DE, Bairn DS, Ho KK, et al. Stent thrombosis in the modem era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-71.
13. Sekiguchi M, Hoshizaki H, Adachi H, Ohshima S, Taniguchi K, Kurabayashi M. Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: A randomized comparison of ticlopidine and cilostazol. Circ J 2004; 68: 610-4.
14. Dangas G, Aymong ED, Mehran R, et al. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infartion and usefulness of abciximab (the CADILLAC trial). Am J Cardiol 2004; 94: 983-8.
15. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-9.
16. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005; 45: 995-8.
17. Ishikawa T, Mutoh M, Fuda Y, et al. Documented subacute stent thrombosis within 30 days after stenting with sirolimus-eluting stent (cypher®) for acute myocardial infarction. Circ J 2006; 70: 1091-2.
18. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21.
19. Ishikawa T, Mori C, Abe Y, et al. A case report of late coronary stent thrombosis manifested as acute myocardial infarction 19 months after stenting. Jpn Heart J 2004; 45: 147-52.
20. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. J Am Coll Cardiol 1993; 21: 1557-63.
21. Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a strolimus-eluting stent versus a standard stents in patients at high risk for coronary restenosis. Circulation 2004; 109: 634-40.
22. Prati F, Di Mario C, Moussa I, et al. In-stent neointimal proliferation correlates with the amount of residual plaque burden outside the stent: an intravascular ultrasound study. Circulation 1999; 99: 1011-4.
23. Mutoh M, Ishikawa T, Sakamoto H, et al. Facilitation of rotablator-stenting by measuring angiographic lesion length with the navicath (type-MUTO), a New Measuring Microcatheter. Int Heart J 2006; 47: 139-46.
24. Chen ZM, Jiang LX, Chen YP, et al; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1607-21.
25. Ishikawa T, Yagi H, Ogawa T, et al. Deteriorative effect of smoking on target lesion revascularization after implantation of coronary stents with diameter of 3.0 mm or less. Circ J 2005; 69: 227-31.
26. Cicek D, Doven O, Pekdemir H, et al. Procedural results and distal embolization after saphenous vein graft stenting and angioplasty for in-stent restenosis of grafts. Jpn Heart J 2004; 45: 561-71.
27. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 2005; 111: 3435-42.
28. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988; 78: 486-502.
29. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-9.
30. Minutello RM, Bhagan S, Feldman D, Sharma A, Hong MK, Wong SC. Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents. Am J Cardiol 2006; 97:499-501.
31. Lemos PA, Saia F, Lighart JM, et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003; 108: 257-60.
32. Doven O, Ozcan TI, Cicek D, et al. Angiographic and clinical outcome following Paclitaxel-eluting stent (taxus) implantation. Int Heart J 2006; 47: 1-12.
33. Sousa JE, Costa MA, Abizaid A, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 2005; 111: 2326-9.